Location History:
- Reinheim, DE (2021)
- Darmstadt, DE (2023)
Company Filing History:
Years Active: 2021-2023
Title: Innovations in Drug Development: The Works of Inventor Doreen Musch
Introduction: Doreen Musch is a distinguished inventor based in Reinheim, Germany, known for her significant contributions to the field of pharmaceutical sciences. With a total of four patents to her name, Musch focuses on developing novel compounds aimed at treating hyperproliferative diseases. Her work exemplifies the vital intersection of scientific research and patent law in the advancement of medical therapies.
Latest Patents: Among her notable inventions are two recent patents that highlight her innovative approach to drug development. The first patent, titled "Pyrimidinone derivatives as SHP2 antagonists," describes a series of pyrimidinone derivatives and their use in treating hyperproliferative disorders in mammals, particularly humans. This invention involves pharmaceutically acceptable salts of these compounds, providing a foundation for potential therapeutic applications.
The second patent titled "Carboxamide-pyrimidine derivatives as SHP2 antagonists," similarly focuses on the development of carboxamide-pyrimidine derivatives for the treatment of hyperproliferative diseases. This invention also emphasizes the preparation of pharmaceutical compositions incorporating these derivatives, showcasing Musch's dedication to addressing significant health challenges through innovative solutions.
Career Highlights: Doreen Musch is currently affiliated with Merck Patent GmbH, where she contributes her expertise and innovative thinking to a team focused on delivering groundbreaking medical solutions. Her role signifies her commitment to advancing pharmaceutical research and development through intellectual property.
Collaborations: Throughout her career, Musch has collaborated with esteemed colleagues, including Roch Boivin and Theresa L Johnson. These partnerships underscore the importance of teamwork in the pursuit of scientific advancements, merging diverse ideas to foster creativity in research and innovation.
Conclusion: Doreen Musch's contributions to the pharmaceutical field through her patents demonstrate her exceptional skills as an inventor. Her ongoing research and development efforts play a critical role in the fight against pervasive health issues, highlighting the importance of innovation in the medical sector. As she continues her work at Merck Patent GmbH, Musch remains a prominent figure in the landscape of pharmaceutical inventions aimed at improving patient outcomes.